Related Experiment Videos
Circumventing adenovirus immune response to achieve long-term correction of genetic diseases
Human Gene Therapy
|April 3, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[The behavioral goals of the coronary patient: No longer smoke, eat better, move more and better].
Annales de cardiologie et d'angeiologie·2018
Evaluation of short food-frequency questionnaires to assess the dietary pattern associated with atherosclerotic cardiovascular diseases.
Journal de medecine vasculaire·2018
Genotoxic risk of ethyl-paraben could be related to telomere shortening.
Journal of applied toxicology : JAT·2016
Effect of phytosterols/stanols on LDL concentration and other surrogate markers of cardiovascular risk.
Diabetes & metabolism·2014
Cardiovascular risk and lifestyle habits of consumers of a phytosterol-enriched yogurt in a real-life setting.
Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2014
Use of primary cultures of rat hepatocytes to predict toxicity in the early development of new chemical entities.
Toxicology in vitro : an international journal published in association with BIBRA·2010
Automated Production of Gene-Edited CAR-T Cells for People Living with HIV.
Human gene therapy·2026
Development of an AAV-Encoded Adenine Base Editor for Duchenne Muscular Dystrophy.
Human gene therapy·2026
Redox-metabolic cascade NIR-II prodrug for synchronizing compensatory HSPs/P-gp feedback with mitophagy flux impairment against intrinsic thermotolerance.
International journal of pharmaceutics: X·2026
HDAC inhibitors in cancer therapy: sensitization mechanisms, combination strategies, and translational challenges.
Frontiers in cell and developmental biology·2026
Beyond vitamin D: integrating nuclear receptor signaling networks in periodontal health and disease.
Frontiers in physiology·2026
Cellular signaling meets bacterial infection: the integrative role of STAT3.
Frontiers in cellular and infection microbiology·2026